Revisiting the OGIPRO Trial: Dynamic Electronic Patient-Reported Outcomes Compared with EQ-5D-5L in HER2-Positive Breast Cancer
Overall, dynamic ePRO systems provide validated, high-resolution longitudinal patient data and represent a scalable foundation for patient monitoring and data-driven decision support in oncology, including future AI-based precision-medicine applications.
Authors
- Andreas Trojan (ORCID: https://orcid.org/0000-0001-7257-9312)
- David Blum (ORCID: https://orcid.org/0000-0003-2473-7069)
- Anatol Aicher (ORCID: https://orcid.org/0009-0001-5554-086X)
- Marcus Vetter (ORCID: https://orcid.org/0000-0002-1785-4876)
Institutions
- University of Basel (CH)
- University of Zurich (CH)
- University Hospital of Zurich (CH)
- Brustzentrum Klinik St. Anna (CH)
- Department of Biomedicine Basel (CH)
Publication Details
- Journal
- Cancers
- Published
- 2026-02-13
- DOI
- https://doi.org/10.3390/cancers18040614
- Primary Topic
- Cancer survivorship and care
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Swiss Tumor Institute